Wednesday, 22. July 2026 · Next update: 22:00 DE EN Log in
Cassandra.news
Tomorrow's news. Today.
📈 Economy · Next Week

Gold (XAU/USD Spot) closes above $4,200 per troy ounce on July 31, 2026

Pending ✦ AI-generated prediction Published on 22. July 2026 · Predicted for 31. July 2026 · Based on: Speculative
Probability
52%

Gold closed at approx. $4,144–4,152/oz on July 22, 2026 (Trading Economics) — a multi-week high driven by safe-haven demand (US-Iran tensions, Strait of Hormuz) and USD weakness (EUR/USD 1.1411). Reaching $4,200 by July 31 requires ~+1.2% gain. Supporting factors: daily momentum +1.81% on July 22, WTI oil also surging (+3–4%, $84–88), geopolitics remaining elevated. Countering: Gold could consolidate after the rally; US GDP data (July 30) could strengthen the dollar. No specific Polymarket/Kalshi market for Gold >$4,200 by July 31 found; internal estimate based on trend extrapolation, implied volatility (XAU IV ~13%) and macro environment.

Data basis for this prediction
  • Trading Economics – Gold XAU/USD: 4.144,83 USD, Stand 22. Juli 2026, +1,81 % Tagesveränderung
  • FX Daily Report – WTI Crude Oil July 22, 2026: +3–4 % auf 84–88 USD/Barrel (Geopolitik)
  • Trading Economics – EUR/USD: 1,1411, Stand 22. Juli 2026

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
Related Predictions
📈 Economy ✦ AI

Eli Lilly and Company (NYSE: LLY) beats Q2 2026 earnings (August 5, 2026) adjusted Non-GAAP EPS consensus of approx. $8.89 per share

Eli Lilly reports on August 5, 2026. The EPS consensus per Hudson Labs is ~$8.89 adjusted Non-GAAP EPS. Eli Lilly has beaten estimates for eight consecutive quarters, driven by explosive growth of Mounjaro (tirzepatide, diabetes/GLP-1) and Zepbound (obesity). The GLP-1 segment grows double-digits and routinely outpaces analyst estimates. No Polymarket market available; assessment based on ~85–90% historical beat rate over the last 8 quarters. Risk: potential supply constraints or price pressure from IRA negotiations.

73%
Next Month · Predicted for 5. Aug 2026
📈 Economy ✦ AI

Intel Corporation (NASDAQ: INTC) beats Q2 2026 earnings (July 23, 2026, after market close) adjusted Non-GAAP EPS consensus of approx. $0.21 per share

Intel reports after market close on July 23, 2026. Alphastreet consensus is ~$0.21 adjusted Non-GAAP EPS on revenue of $14.42B. Intel has beaten estimates four consecutive quarters and is in a turnaround phase with growing AI infrastructure (Gaudi, Xeon) bookings. Analyst expectations remain conservative after a long negative streak, offering upside surprise potential. No Polymarket market available; probability based on ~60–65% historical beat rate over the last 12 quarters and positive sector dynamics this quarter (GE Aerospace: +37% EPS beat on July 22, 2026).

62%
Tomorrow · Predicted for 23. Jul 2026
📈 Economy ✦ AI

US GDP Q2 2026 Advance Estimate (BEA, July 30, 2026, 8:30 a.m. EDT) shows annualized growth above 2.5% quarter-on-quarter

The BEA publishes the first estimate of US GDP for Q2 2026 on July 30. The Philadelphia Fed consensus (Survey of Professional Forecasters) is 2.1% annualized, while the Atlanta Fed GDPNow model last showed 3.0% (as of approx. June 2026). This ~1 percentage point divergence signals stronger activity data than the consensus anticipates. Manifold Markets hosted a related question with implied probability of ~38–42% for >2.5%. Goldman Sachs sees 2026 US growth at 2.5%. Counterforces: tariff effects and weak net exports could weigh on GDP. Our assessment: 40%, aligned with Manifold-level.

40%
Next Week · Predicted for 30. Jul 2026